Le réseau international des Instituts Pasteur
Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 10, Octobre 2013
Le réseau international des Instituts Pasteur
Page(s) 912 - 917
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20132910021
Publié en ligne 18 octobre 2013
  1. George KM, Chatterjee D, Gunawardana G, et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999 ; 283 : 854–857. [CrossRef] [PubMed]
  2. Stinear TP, Mve-Obiang A, Small PL, et al. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci USA 2004 ; 101 : 1345–1349. [CrossRef]
  3. Marsollier L, Brodin P, Jackson M, et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog 2007 ; 3 : e62. [CrossRef] [PubMed]
  4. Marsollier L, Prevot G, Honore N, et al. Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin. Int J Antimicrob Agents 2003 ; 22 : 562–566. [CrossRef] [PubMed]
  5. MacCallum P, Tolhurst JC, et al. A new mycobacterial infection in man. J Pathol Bacteriol 1948 ; 60 : 93–122. [CrossRef]
  6. Tolhurst JC, Buckle G. A new mycobacterial infection in man; experimental investigations in laboratory animals. J Pathol Bacteriol 1948 ; 60 : 102–110. [PubMed]
  7. Janssens PG, Quertinmont MJ, Sieniawski J, Gatti F. Necrotic tropical ulcers and mycobacterial causative agents. Trop Geogr Med 1959 ; 11 : 293–312. [PubMed]
  8. Dodge OG, Lunn HF. Buruli ulcer: a mycobacterial skin ulcer in a Uganda child. J Trop Med Hyg 1962 ; 65 : 139–142. [PubMed]
  9. Uganda Buruli Group. Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans R Soc Trop Med Hyg 1971 ; 65 : 763–775. [CrossRef] [PubMed]
  10. Uganda Buruli Group. Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli Group. Br Med J 1970 ; 2 : 390–393. [CrossRef] [PubMed]
  11. Asiedu K, Etuaful S. Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg 1998 ; 59 : 1015–1022. [PubMed]
  12. Toll A, Gallardo F, Ferran M, et al. Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Clin Exp Dermatol 2005 ; 30 : 649–651. [CrossRef] [PubMed]
  13. Delaporte E, Savage C, Alfandari S, et al. Ulcère de Buruli chez une malade zaïroise infectée par le virus de l’immunodéficience humaine. Ann Dermatol Venereol 1994 ; 121 : 557–560. [PubMed]
  14. Asiedu K, Sherpbier R, Raviglione MC., Buruli ulcer Mycobacterium ulcerans infection. WHO Global Buruli ulcer initiative. Report 2000. Geneva, Switzerland : World Health Organisation, 2000.
  15. Fraga AG, Cruz A, Martins TG, et al. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infect Immun 2010 ; 79 : 421–430. [CrossRef] [PubMed]
  16. Torrado E, Adusumilli S, Fraga AG, et al. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun 2007 ; 75 : 3979–3988. [CrossRef] [PubMed]
  17. Etuaful S, Carbonnelle B, Grosset J, et al. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 2005 ; 49 : 3182–3186. [CrossRef] [PubMed]
  18. Chauty A, Ardant MF, Adeye A, et al. Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 2007 ; 51 : 4029–4035. [CrossRef] [PubMed]
  19. Marsollier L, Deniaux E, Brodin P, et al. Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. PLoS Med 2007 ; 4 : e64. [CrossRef] [PubMed]
  20. Marsollier L, Robert R, Aubry J, et al. Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 2002 ; 68 : 4623–4628. [CrossRef] [PubMed]
  21. Portaels F, Elsen P, Guimaraes-Peres A, et al. Insects in the transmission of Mycobacterium ulcerans infection. Lancet 1999 ; 353 : 986. [CrossRef] [PubMed]
  22. Portaels F, Meyers WM, Ablordey A, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2008 ; 2 : e178. [CrossRef] [PubMed]
  23. Wallace JR, Gordon MC, Hartsell L, et al. Interaction of Mycobacterium ulcerans with mosquito species: implications for transmission and trophic relationships. Appl Environ Microbiol 2010 ; 76 : 6215–6222. [CrossRef] [PubMed]
  24. Pouillot R, Matias G, Wondje CM, et al. Risk factors for Buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis 2007 ; 1 : e101. [CrossRef] [PubMed]
  25. Landier J, Boisier P, Fotso Piam F, et al. Adequate wound care and use of bed nets as protective factors against Buruli ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis 2011 ; 5 : e1392. [CrossRef] [PubMed]
  26. Marion E, Landier J, Boisier P, et al. Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis 2011 ; 17 : 551–553. [CrossRef] [PubMed]
  27. Kibadi K, Aujoulat I, Meyers WM, et al. Étude des appellations et des représentations attachées à l’infection à Mycobacterium ulcerans dans différents pays endémiques d’Afrique. Med Trop 2007 ; 67 : 241–248.
  28. Marsollier L, Aubry J, Milon G, Brodin P. Punaises aquatiques et transmission de Mycobacterium ulcerans. Med Sci (Paris) 2007 ; 23 : 572–575. [CrossRef] [EDP Sciences] [PubMed]
  29. Marion E, Eyangoh S, Yeramian E, et al. Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts, vectors. PLoS Negl Trop Dis 2010 ; 4 : e731. [CrossRef] [PubMed]
  30. Mabèrou Houngbédji G, Frenette J. L’ulcère de Buruli. Med Sci (Paris) 2011 ; 27 : 187–192. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.